English
This article is from Oman Journal of Ophthalmology , volume 4 . Abstract Our objective is to report a case of bilateral nodular scleritis in a 34-year-old patient, resistant to steroids and traditional disease modifying anti-rheumatic drugs, who was successfully treated with subcutaneous injections of 40 mg adalimumab. Adalimumab resulted in rapid control of scleritis in both eyes within 3 months with no recurrence over 5 years of follow-up. No side effects were reported during treatment.Although a large prospective study and a longer follow-up are required to reach a conclusive result, adalimumab has a potential role in the treatment of the above condition with the control of inflammation.
Sign in with your free account to read, download EPUBs or listen.
Ebook · Adalimumab in the treatment of recurrent idiopathic bilateral nodular scleritis. · Bawazeer, Ahmed M., Raffa, Lina H. · Internet Archive